Mitsubishi Chemical Group (TYO:4188) anticipates a 20 billion yen impairment loss in the third quarter of fiscal 2025 after it halted plans for a new methyl methacrylate (MMA) monomer plant in Geismar, Louisiana, US, according to its Tuesday filing.
This followed the Japanese company's failed negotiations with customers in securing long-term commitments amid rising capital costs from inflation.
Mitsubishi Chemical Group slashed its attributable profit forecast for the fiscal year ending March 31, 2025, to 52 billion yen from 119.6 billion and sales revenue to 4.39 billion yen from 4.47 billion yen.
Mitsubishi Chemical Group's shares shed over 2% at market close.
Price (JPY): $803.30, Change: $-17, Percent Change: -2.02%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.